0001567619-22-007140.txt : 20220317 0001567619-22-007140.hdr.sgml : 20220317 20220317161908 ACCESSION NUMBER: 0001567619-22-007140 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20220317 DATE AS OF CHANGE: 20220317 EFFECTIVENESS DATE: 20220317 FILER: COMPANY DATA: COMPANY CONFORMED NAME: PolyCore Therapeutics, Inc. CENTRAL INDEX KEY: 0001914733 IRS NUMBER: 473081314 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-437808 FILM NUMBER: 22748793 BUSINESS ADDRESS: STREET 1: 3180 CHESTNUT STREET, SUITE 104 CITY: PHILADELPHIA STATE: PA ZIP: 19104 BUSINESS PHONE: 484-888-2661 MAIL ADDRESS: STREET 1: 3180 CHESTNUT STREET, SUITE 104 CITY: PHILADELPHIA STATE: PA ZIP: 19104 D 1 primary_doc.xml X0708 D LIVE 0001914733 PolyCore Therapeutics, Inc. 3180 CHESTNUT STREET, SUITE 104 PHILADELPHIA PA PENNSYLVANIA 19104 484-888-2661 DELAWARE None None Corporation true 2022 Kelly Beck 3180 Chestnut Street, Suite 104 Philadelphia PA PENNSYLVANIA 19104 Executive Officer Promoter Director Ms. Beck is the Chief Executive Officer of the Issuer. Frederick Callori 3180 Chestnut Street, Suite 104 Philadephia PA PENNSYLVANIA 19104 Director Chris Garabedian 3180 Chestnut Street, Suite 104 Philadelphia PA PENNSYLVANIA 19104 Director James B. Harris 3180 Chestnut Street, Suite 104 Philadelphia PA PENNSYLVANIA 19104 Director Christopher Cashman 3180 Chestnut Street, Suite 104 Philadelphia PA PENNSYLVANIA 19104 Director Biotechnology Decline to Disclose 06b false 2022-02-11 false true true Common Stock false 0 4713623 4713623 0 false 5 0 0 0 false PolyCore Therapeutics, Inc. /s/ Kelly Beck Kelly Beck Chief Executive Officer of the Issuer 2022-03-17